Literature DB >> 2542312

Cyclic AMP-dependent phosphorylation of glycoprotein Ib inhibits collagen-induced polymerization of actin in platelets.

J E Fox1, M C Berndt.   

Abstract

Platelet function is inhibited by agents such as prostaglandin E1 (PGE1) that elevate the cytoplasmic concentration of cyclic AMP. Inhibition presumably results from the cyclic AMP-stimulated phosphorylation of intracellular proteins. Polypeptides that become phosphorylated are actin-binding protein, P51 (Mr = 51,000), P36 (Mr = 36,000), P24 (Mr = 24,000), and P22 (Mr = 22,000). Recently, we identified P24 as the beta-chain of glycoprotein (GP) Ib, a component of the plasma membrane GP Ib.IX complex. The existence of Bernard-Soulier syndrome, a hereditary disorder in which platelets selectively lack the GP Ib.IX complex, enabled us to examine whether the phosphorylation of GP Ib beta (P24) is responsible for any of the inhibitory effects of elevated cyclic AMP on platelet function. Exposure of control platelets to PGE1 increased phosphorylation of actin-binding protein, P51, P36, GP Ib beta, and P22. Prostaglandin E1 induced the same phosphorylation reactions in Bernard-Soulier platelets, except that of GP Ib beta, which is absent. In control platelets, PGE1 inhibited collagen-induced phosphorylation of myosin light chain, phosphorylation of P47 (an unidentified Mr 47,000 cytoplasmic protein that is phosphorylated by protein kinase C in stimulated platelets), aggregation, and the secretion of granule contents. Despite the absence of GP Ib beta, PGE1 also inhibited these collagen-induced responses in Bernard-Soulier platelets. However, while PGE1 inhibited collagen-induced polymerization of actin in control platelets, it did not inhibit actin polymerization in Bernard-Soulier platelets. These results suggest that cyclic AMP-induced phosphorylation of GP Ib inhibits collagen-induced actin polymerization in platelets. Because actin polymerization is required for at least some of the functional responses of platelets to an agonist, phosphorylation of Gp Ib beta may be one way in which cyclic AMP inhibits platelet function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542312

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Platelet GP Ib/IX/V complex: physiological role.

Authors:  J Rivera; M L Lozano; J Corral; R González-Conejero; C Martínez; V Vicente
Journal:  J Physiol Biochem       Date:  2000-12       Impact factor: 4.158

2.  A new form of macrothrombocytopenia induced by a germ-line mutation in the PRKACG gene.

Authors:  Vladimir T Manchev; Morgane Hilpert; Eliane Berrou; Ziane Elaib; Achille Aouba; Siham Boukour; Sylvie Souquere; Gerard Pierron; Philippe Rameau; Robert Andrews; François Lanza; Regis Bobe; William Vainchenker; Jean-Philippe Rosa; Marijke Bryckaert; Najet Debili; Remi Favier; Hana Raslova
Journal:  Blood       Date:  2014-07-24       Impact factor: 22.113

3.  P1,P4-dithio-P2,P3-monochloromethylene diadenosine 5',5'''-P1,P4-tetraphosphate: a novel antiplatelet agent.

Authors:  S W Chan; S J Gallo; B K Kim; M J Guo; G M Blackburn; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

4.  Functional relationship between cyclic AMP-dependent protein phosphorylation and platelet inhibition.

Authors:  W Siess; E G Lapetina
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

5.  A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V.

Authors:  V Ramakrishnan; F DeGuzman; M Bao; S W Hall; L L Leung; D R Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

6.  Staurosporine both activates and inhibits serine/threonine kinases in human platelets.

Authors:  M Kocher; K J Clemetson
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

7.  Shear-stress-induced von Willebrand factor binding to platelets causes the activation of tyrosine kinase(s).

Authors:  K Razdan; J D Hellums; M H Kroll
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

Review 8.  Biology of Platelet Purinergic Receptors and Implications for Platelet Heterogeneity.

Authors:  Milka Koupenova; Katya Ravid
Journal:  Front Pharmacol       Date:  2018-01-30       Impact factor: 5.810

9.  The 46/50 kDa phosphoprotein VASP purified from human platelets is a novel protein associated with actin filaments and focal contacts.

Authors:  M Reinhard; M Halbrügge; U Scheer; C Wiegand; B M Jockusch; U Walter
Journal:  EMBO J       Date:  1992-06       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.